Pfizer Stock Hits 52-Week Low Amid Continued Downward Trend and Weak Growth Indicators

Pfizer has experienced significant activity today, reaching a new 52-week low of Rs. 3742.9. This decline marks a continuation of a downward trend, with the stock falling for two consecutive days and recording a total drop of 5.36% during this period. The stock opened with a loss of 2.36% and hit an intraday low of Rs. 3742.9, reflecting a decrease of 6.22% at its lowest point.
In terms of performance metrics, Pfizer is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish technical outlook. Over the past year, the stock has underperformed significantly, with a return of -11.41%, compared to the Sensex's decline of only -1.96%.

Financially, Pfizer's long-term growth appears weak, with net sales growing at an annual rate of just 0.46% and operating profit at 4.27% over the last five years. Recent quarterly results have also shown a decline in profit after tax, which fell by 16.6%. The company's valuation remains high, with a price-to-book ratio of 4.9, suggesting it is trading at a premium compared to its peers.